Stanley T Crooke

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Cerebrospinal Fluid

Intellectual Disability

Endoplasmic Reticulum

Top Venues

Nucleic acids research

Nature medicine

Nature biotechnology

Nature reviews. Drug discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Alban Ziegler, Joanne Carroll, Jennifer M Bain, Tristan T Sands, Robert J Fee, David Uher, Cara H Kanner, Jacqueline Montes, Sarah Glass, Julie Douville, Laurence Mignon, Joseph G Gleeson, Stanley T Crooke, Wendy K Chung
Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder. Nature medicine (2024)
Alban Ziegler, Joanne Carroll, Jennifer M Bain, Tristan T Sands, Robert J Fee, David Uher, Cara H Kanner, Jacqueline Montes, Sarah Glass, Julie Douville, Laurence Mignon, Joseph G Gleeson, Stanley T Crooke, Wendy K Chung
Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder. Nature medicine (2024)
Alban Ziegler, Joanne Carroll, Jennifer M Bain, Tristan T Sands, Robert J Fee, David Uher, Cara H Kanner, Jacqueline Montes, Sarah Glass, Julie Douville, Laurence Mignon, Joseph G Gleeson, Stanley T Crooke, Wendy K Chung
Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder. Nature medicine (2024)
Stanley T Crooke
Establishing an environment in which rigorous scientific inquiry is practiced: a personal journey. Nucleic acids research 50 (13) (2022)
Adam J Pollak, Luyi Zhao, Timothy A Vickers, Ian J Huggins, Xue-Hai Liang, Stanley T Crooke
Insights into innate immune activation via PS-ASO-protein-TLR9 interactions. Nucleic acids research 50 (14) (2022)
Brooke A Anderson, Graeme C Freestone, Audrey Low, Cheryl L De-Hoyos, William J Drury Iii, Michael E Østergaard, Michael T Migawa, Michael Fazio, W Brad Wan, Andres Berdeja, Eli Scandalis, Sebastien A Burel, Timothy A Vickers, Stanley T Crooke, Eric E Swayze, Xue-Hai Liang, Thazha P Prakash
Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides. Nucleic acids research 49 (16) (2021)
Xue-Hai Liang, Joshua G Nichols, Cheryl Li De Hoyos, Hong Sun, Lingdi Zhang, Stanley T Crooke
Golgi-58K can re-localize to late endosomes upon cellular uptake of PS-ASOs and facilitates endosomal release of ASOs. Nucleic acids research 49 (14) (2021)
Stanley T Crooke, Brenda F Baker, Rosanne M Crooke, Xue-Hai Liang
Antisense technology: an overview and prospectus. Nature reviews. Drug discovery 20 (6) (2021)
Thazha P Prakash, Jinghua Yu, Wen Shen, Cheryl Li De Hoyos, Andres Berdeja, Hans Gaus, Xue-Hai Liang, Stanley T Crooke, Punit P Seth
Site-specific Incorporation of 2',5'-Linked Nucleic Acids Enhances Therapeutic Profile of Antisense Oligonucleotides. ACS medicinal chemistry letters 12 (6) (2021)
Xue-Hai Liang, Joshua G Nichols, Dario Tejera, Stanley T Crooke
Perinuclear positioning of endosomes can affect PS-ASO activities. Nucleic acids research (2021)
Stanley T Crooke, Punit P Seth, Timothy A Vickers, Xue-Hai Liang
The Interaction of Phosphorothioate-Containing RNA Targeted Drugs with Proteins Is a Critical Determinant of the Therapeutic Effects of These Agents. Journal of the American Chemical Society 142 (35) (2020)
Wen Shen, Cheryl L De Hoyos, Michael T Migawa, Timothy A Vickers, Hong Sun, Audrey Low, Thomas A Bell, Meghdad Rahdar, Swagatam Mukhopadhyay, Christopher E Hart, Melanie Bell, Stan Riney, Susan F Murray, Sarah Greenlee, Rosanne M Crooke, Xue-Hai Liang, Punit P Seth, Stanley T Crooke
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index. Nature biotechnology 37 (6) (2019)